Ann Arbor, MI, United States of America

Akira Abe


 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Akira Abe: Innovator in Therapeutic Methods

Introduction

Akira Abe is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of therapeutic methods, particularly in the treatment of various diseases. With a total of 7 patents to her name, her work has had a substantial impact on medical science.

Latest Patents

Among her latest patents, Akira Abe has developed glucosylceramide synthase inhibitors and therapeutic methods using the same. These inhibitors and compositions are disclosed for their potential in treating diseases such as Gaucher disease and Fabry disease. Additionally, she has created methods for reducing the accumulation of intracellular tingible body macrophages. This invention focuses on the diagnosis and treatment of systemic lupus erythematosus and drug-induced systemic lupus erythematosus, utilizing a lysosomal phospholipase A2.

Career Highlights

Akira Abe is affiliated with the University of Michigan, where she continues her research and innovation. Her work has been instrumental in advancing therapeutic approaches for autoimmune disorders and other medical conditions.

Collaborations

She has collaborated with notable colleagues, including James A Shayman and Robert Kelly, further enhancing the scope and impact of her research.

Conclusion

Akira Abe's contributions to the field of therapeutic methods exemplify her dedication to improving healthcare through innovation. Her patents reflect a commitment to addressing complex medical challenges, making her a valuable figure in the realm of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…